The goal of this randomized controlled clinical trial is to test the efficacy \& safety of stromal vascular fraction in treatment of AGA \& compare it to PRP The main questions it aims to answer are:
* efficacy \& safety of SVF for treatment of AGA patients * comparing it to PRP in treatment of AGA Participants will receive a single session of SVF in one half of the scalp \& a single session of PRP in the other half.
18 years or older.
Hamilton score I to VI in male patients.
Patients with active infection, malignancy, autoimmune disease, and on current anticoagulant therapy.
Patient on chemotherapy during the last 5 years.
patients on topical or systemic treatment of AGA